Article Data

  • Views 1705
  • Dowloads 151

Case Report

Open Access

Chryseobacterium gleum infection in patient with extreme malnutrition and hepatic lesion – case report

  • DIJANA VARDA BRKIĆ1
  • OZRENKA ZLOPAŠA2
  • BRANKA BEDENIĆ1,3
  • VANDA PLEČKO1,3

1Department of Clinical and Molecular Microbiology, Clinical Hospital Centre Zagreb, Kišpatićeva 12, Zagreb, Croatia

2Division of Intensive Care Medicine, Department of Internal Medicine, Clinical Hospital Centre Zagreb, Kišpatićeva 12, Zagreb, Croatia

3School of Medicine, University of Zagreb, Zagreb, Croatia

DOI: 10.22514/SV101.062015.13 Vol.10,Issue S1,June 2015 pp.50-52

Published: 22 June 2015

*Corresponding Author(s): DIJANA VARDA BRKIĆ E-mail: dijanavb098@gmail.com

Abstract

Chrysobacterium gleum is a nonmotile, oxidase positive, non-fermentative un-sporulate Gram-negative bacillus, bacteria belonging to the genus Chrysobacterium. Infections caused by Chrysobacterium spp are usually health care associated and the most frequent in immunocompromised patients and neonates.

In this report we present a case of a 35-year-old female patient admitted to the hospital for extreme malnutrition and a hepatic le-sion. Chrysobacterium gleum was isolated from tracheal aspirate and blood culture. The strain was identified with Microflex MALDI Biotyper (Bruker Daltonik, Fre-mont, CA). The patient was successfully treated with piperacillin/tazobactam. Em-pirical therapy is difficult due to intrinsic resistance to most antimicrobials which are usually effective against Gram-negative bacteria.

Keywords

Chrysobacterium gleum, MAL-DI-TOF, susceptibility pattern, piperacillin/tazobactam, health care associated infec-tions

Cite and Share

DIJANA VARDA BRKIĆ,OZRENKA ZLOPAŠA,BRANKA BEDENIĆ,VANDA PLEČKO. Chryseobacterium gleum infection in patient with extreme malnutrition and hepatic lesion – case report. Signa Vitae. 2015. 10(S1);50-52.

References

1. 8th Mandell GL, Douglas, and Bennett JE. Principles and Practice of Infectious Diseases, Edition. New York Elsevier; 2010: 3022-3023.

2. Lo HH, Chang SM. Identification, characterization, and biofilm formation of clinical Chryseobacterium gleum isolates. Diagn Microbiol Infect Dis. 2014; 79 (3): 298-302

3. Lee K, Lim YS, Yong D, et al.. Evaluation of the Hodge test and the imipenem-EDTA-double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41:4623- 4629.

4. Clinical and Laboratory Standards Institute 2013. Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informa-tional Supplement, M100-S23.Wayne, PA: CLSI

5. Elwell LP, Falkow S. The characterizatio of R plasmids and the detection of  plasmid-specified genes. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 2nd edn. Baltimore MD: Williams and Wilkins, 1986: 683-721.

6. Poirel L, Walsh TR, Cuveiller V, et al.Multiplex PCR for detection of acquired carbapenemases genes. Diagn Microbiol Infect Dis 2011; 0:119-125.

7. Virok DP, Abrok M, Szel B, et al. Chryseobacterium gleum – a novel bacterium species detected in neonatal respiratory tract infec-tions. J Matern Fetal Neonatal Med. 2014; 14.

8. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Website with MIC distribution. (http://mic.eucasr.org)/available from March 2010).

9. Kirby JT, Sader HS, Walsh TR, et al. Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacte-rium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

10. Bridet L, Martin JJ, Nuno JL. Acute liver damage and anorexia nervosa: a case report. Turk J Gastroenterol. 2014; 25(2):205-8.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top